Whom to Evaluate for Cardiac Amyloidosis: ASNC/Multisocietal Expert Consensus Recommendations

Date: December 11, 2019

Time: 12:00PM - 01:00PM

You must be registered to participate!

Learning Objectives:

  • Review the Expert Consensus Recommendations (ECR) for cardiac amyloidosis imaging in clinical practice
  • Demonstrate appropriate use of the ECR in clinical practice using multiple case studies
  • Provide clinical insights to diagnosis and management of cardiac amyloidosis

Agenda

  • Overview of Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis
  • Case Studies
    • Identifying cardiac involvement: No cardiac symptoms
    • Screening for cardiac amyloidosis: New symptomatic heart failure
    • Evaluation of biopsy proven AL amyloidosis
    • Evaluation of biopsy proven ATTR amyloidosis
    • Follow-up testing: New or worsening cardiac symptoms
    • Other clinical conditions associated with amyloidosis
  • Summary and recommendations

This activity is sponsored by Pfizer. No CME/CE credit is available for this webinar.

Moderator(s):
Speaker(s):
  • Jamieson M. Bourque, MD, MHS, FASNC, Associate Professor of Medicine and Radiology, University of Virginia Health Systems
  • Brett W. Sperry, MD, Saint Luke’s Mid America Heart Institute, Kansas City, MO
  • Mathew S. Maurer, MD, Columbia University Medical Center, New York, NY
  • Rodney H. Falk, MD, Associate Professor, Harvard Medical School, Cardiovascular Medicine, Director, Cardiac Amyloidosis Program Brigham and Women’s Hospital Boston, MA